Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

A new bioreactor system uses hollow fibers to deliver nutrients to lab-grown tissue, enabling scalable cultured chicken meat ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

A bioreactor that mimics a circulatory system can deliver nutrients and oxygen to artificial tissue, enabling the production ...

Title : Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients. Session : Late-breaking science in heart failure, cardiomyopathies, pulmonary ...

Learn more about whether Amarin Corporation plc or Twist Bioscience Corporation is a better investment based on AAII's A+ ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and therefore flagged by the Imperva network. Imperva displays this page for you ...

Learn more about whether Neurocrine Biosciences, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...